Alphabet's Isomorphic Labs reportedly raising $2B+ for drug-discovery AI

Isomorphic Labs is in talks to raise more than $2B, with Thrive Capital expected to lead and existing backers participating. The round would significantly accelerate the DeepMind spinout's AI-driven drug development pipeline.